Circulating insulin-like growth factor I and cognitive function: Neuromodulation throughout the lifespan

Progress in Neurobiology

Volumn 89, Issue 3, 2009, Pages 256-265

  Aleman, André ^a,b   Torres Alemán, Ignacio ^c,d  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c INSTITUTO CAJAL   (Spain)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

Cognition; IGF I; Neuromodulation; Neuronal plasticity

Indexed keywords

4 AMINOBUTYRIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUTAMIC ACID; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; INSULIN RECEPTOR SUBSTRATE; INSULIN RECEPTOR SUBSTRATE 1; MYOCYTE ENHANCER FACTOR 2; PLACEBO; RECOMBINANT SOMATOMEDIN C; SEROTONIN UPTAKE INHIBITOR; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BEHAVIOR; BLOOD BRAIN BARRIER; BRAIN LEVEL; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; EXERCISE; GROWTH HORMONE DEFICIENCY; HEREDITARY ATAXIA; HOMEOSTASIS; HUMAN; HYPERCORTISOLISM; LIFESPAN; MENTAL DETERIORATION; MENTAL DISEASE; MOLECULAR DYNAMICS; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROFIBRILLARY TANGLE; NEUROLOGIC DISEASE; NEUROMODULATION; NEUROPROTECTION; NEUROPSYCHOLOGICAL TEST; NEUROTRANSMISSION; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGULATORY MECHANISM; REVIEW; UPREGULATION;

ANIMALS; BRAIN; COGNITION; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MENTAL DISORDERS; NERVOUS SYSTEM DISEASES; NEURONAL PLASTICITY; SYNAPTIC TRANSMISSION;

EID: 70350335299     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2009.07.008     Document Type: Review

References (134)

1. Aberg N.D., Brywe K.G., and Isgaard J. Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. ScientificWorldJournal 6 (2006) 53-80
2. Adem A., Jossan S.S., d'Argy R., Gillberg P.G., Nordberg A., Winblad B., and Sara V. Insulin-like growth factor 1 (IGF-I) receptors in the human brain: quantitative autoradiographic localization. Brain Res. 503 (1989) 299-303
3. Al-Delaimy W.K., von Muhlen D., and Barrett-Connor E. Insulinlike growth factor-1, insulinlike growth factor binding protein-1, and cognitive function in older men and women. J. Am. Geriatr. Soc. 57 (2009) 1441-1446
4. Aleman A., Verhaar H.J., De Haan E.H., De Vries W.R., Samson M.M., Drent M.L., Van der Veen E.A., and Koppeschaar H.P. Insulin-like growth factor-I and cognitive function in healthy older men. J. Clin. Endocrinol Metab. 84 (1999) 471-475
5. Arai J.A., Li S., Hartley D.M., and Feig L.A. Transgenerational rescue of a genetic defect in long-term potentiation and memory formation by juvenile enrichment. J. Neurosci. 29 (2009) 1496-1502
6. Arwert L.I., Deijen J.B., and Drent M.L. Effects of an oral mixture containing glycine, glutamine and niacin on memory, GH and IGF-I secretion in middle-aged and elderly subjects. Nutr. Neurosci. 6 (2003) 269-275
7. Arwert L.I., Deijen J.B., and Drent M.L. The relation between insulin-like growth factor I levels and cognition in healthy elderly: a meta-analysis. Growth Horm. IGF Res. 15 (2005) 416-422
8. Arwert L.I., Veltman D.J., Deijen J.B., Lammertsma A.A., Jonker C., and Drent M.L. Memory performance and the growth hormone/insulin-like growth factor axis in elderly: a positron emission tomography study. Neuroendocrinology 81 (2005) 31-40
9. Baum H.B., Katznelson L., Sherman J.C., Biller B.M., Hayden D.L., Schoenfeld D.A., Cannistraro K.E., and Klibanski A. Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency. J. Clin. Endocrinol. Metab. 83 (1998) 3184-3189
10. Black I.B. Trophic regulation of synaptic plasticity. J. Neurobiol. 41 (1999) 108-118
11. Bondanelli M., Ambrosio M.R., Onofri A., Bergonzoni A., Lavezzi S., Zatelli M.C., Valle D., Basaglia N., and degli Uberti E.C. Predictive value of circulating insulin-like growth factor I levels in ischemic stroke outcome. J. Clin. Endocrinol. Metab. 91 (2006) 3928-3934
12. Bondy C.A., and Cheng C.M. Signaling by insulin-like growth factor 1 in brain. Eur. J. Pharmacol. 490 (2004) 25-31
13. Brabant G., Von Zur M.A., Wuster C., Ranke M.B., Kratzsch J., Kiess W., Ketelslegers J.M., Wilhelmsen L., Hulthen L., Saller B., Mattsson A., Wilde J., Schemer R., and Kann P. Serum insulin-like growth factor I Reference values for an automated chemiluminescence immunoassay system: results from a multicenter study. Horm. Res. 60 (2003) 53-60
14. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., and Greenberg M.E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96 (1999) 857-868
15. Burns A., and Zaudig M. Mild cognitive impairment in older people. Lancet 360 (2002) 1963-1965
16. Carro E., Nunez A., Busiguina S., and Torres-Aleman I. Circulating insulin-like growth factor I mediates effects of exercise on the brain. J. Neurosci. 20 (2000) 2926-2933
17. Carro E., Trejo J.L., Nunez A., and Torres-Aleman I. Brain repair and neuroprotection by serum insulin-like growth factor I. Mol. Neurobiol. 27 (2003) 153-162
18. Carro E., and Torres-Aleman I. The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease. Eur. J. Pharmacol. 490 (2004) 127-133
19. Castro-Alamancos M.A., and Torres-Aleman I. Long-term depression of glutamate-induced gamma-aminobutyric acid release in cerebellum by insulin-like growth factor I. Proc. Natl. Acad. Sci. USA 90 (1993) 7386-7390
20. Castro-Alamancos M.A., and Torres-Aleman I. Learning of the conditioned eye-blink response is impaired by an antisense insulin-like growth factor I oligonucleotide. Proc. Natl. Acad. Sci. USA 91 (1994) 10203-10207
21. Chesik D., De Keyser J., and Wilczak N. Insulin-like growth factor system regulates oligodendroglial cell behavior: therapeutic potential in CNS. J. Mol. Neurosci. 35 (2008) 81-90
22. Clark R.G. Recombinant human insulin-like growth factor I (IGF-I): risks and benefits of normalizing blood IGF-I concentrations. Horm. Res. 62 Suppl. 1 (2004) 93-100
23. Clemmons D.R. Role of insulin-like growth factor iin maintaining normal glucose homeostasis. Horm. Res. 62 Suppl. 1 (2004) 77-82
24. Clemmons D.R., Sleevi M., Allan G., and Sommer A. Effects of combined recombinant insulin-like growth factor (IGF)-I and IGF binding protein-3 in type 2 diabetic patients on glycemic control and distribution of IGF-I and IGF-II among serum binding protein complexes. J. Clin. Endocrinol. Metab. 92 (2007) 2652-2658
25. Cui Q.L., Zheng W.H., Quirion R., and Almazan G. Inhibition of SRC-like kinase reveals Akt-dependent and-independent pathways in IGF-I-mediated oligodendrocyte progenitor survival. J. Biol. Chem. 280 (2005) 8918-8928
26. D'Ercole A.J., Ye P., Calikoglu A.S., and Gutierrez-Ospina G. The role of the insulin-like growth factors in the central nervous system. Mol. Neurobiol. 13 (1996) 227-255
27. Davila D., Piriz J., Trejo J.L., Nunez A., and Torres-Aleman I. Insulin and insulin-like growth factor I signalling in neurons. Front Biosci. 12 (2007) 3194-3202
28. Deijen J.B., de Boer H., Blok G.J., and van der Veen E.A. Cognitive impairments and mood disturbances in growth hormone deficient men. Psychoneuroendocrinology 21 (1996) 313-322
29. Deijen J.B., de Boer H., and van der Veen E.A. Cognitive changes during growth hormone replacement in adult men. Psychoneuroendocrinology 23 (1998) 45-55
30. Delcourt N., Thouvenot E., Chanrion B., Galeotti N., Jouin P., Bockaert J., and Marin P. PACAP type I receptor transactivation is essential for IGF-I receptor signalling and antiapoptotic activity in neurons. EMBO J. 26 (2007) 1542-1551
31. Denley A., Carroll J.M., Brierley G.V., Cosgrove L., Wallace J., Forbes B., and Roberts Jr. C.T. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors. Mol. Cell. Biol. 27 (2007) 3569-3577
32. Deuschle M., Blum W.F., Strasburger C.J., Schweiger U., Weber B., Körner A., Standhardt H., Gotthardt U., Schmider J., Pflaum C.D., and Heuser I. Insulin-like growth factor-I (IGF-I) plasma concentrations are increased in depressed patients. Psychoneuroendocrinology 22 (1997) 493-503
33. Diano S., Farr S.A., Benoit S.C., McNay E.C., da S.I., Horvath B., Gaskin F.S., Nonaka N., Jaeger L.B., Banks W.A., Morley J.E., Pinto S., Sherwin R.S., Xu L., Yamada K.A., Sleeman M.W., Tschop M.H., and Horvath T.L. Ghrelin controls hippocampal spine synapse density and memory performance. Nat. Neurosci. 9 (2006) 381-388
34. Dik M.G., Pluijmm S.M., Jonker C., Deeg D.J., Lomecky M.Z., and Lips P. Insulin-like growth factor I (IGF-I) and cognitive decline in older persons. Neurobiol. Aging 24 (2003) 573-581
35. Ding Q., Vaynman S., Akhavan M., Ying Z., and Gomez-Pinilla F. Insulin-like growth factor I interfaces with brain-derived neurotrophic factor-mediated synaptic plasticity to modulate aspects of exercise-induced cognitive function. Neuroscience 140 (2006) 823-833
36. Fernandez A.M., Fernandez S., Carrero P., Garcia-Garcia M., and Torres-Aleman I. Calcineurin in reactive astrocytes plays a key role in the interplay between proinflammatory and anti-inflammatory signals. J. Neurosci. 27 (2007) 8745-8756
37. Fernandez S., Fernandez A.M., Lopez-Lopez C., and Torres-Aleman I. Emerging roles of insulin-like growth factor-I in the adult brain. Growth Horm. IGF Res. 17 (2007) 89-95
38. Fernandez-Galaz M.C., Morschl E., Chowen J.A., Torres-Aleman I., Naftolin F., and Garcia-Segura L.M. Role of astroglia and insulin-like growth factor-I in gonadal hormone-dependent synaptic plasticity. Brain Res. Bull. 44 (1997) 525-531
39. Flavell S.W., Cowan C.W., Kim T.K., Greer P.L., Lin Y., Paradis S., Griffith E.C., Hu L.S., Chen C., and Greenberg M.E. Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number. Science 311 (2006) 1008-1012
40. Foster L.A., Ames N.K., and Emery R.S. Food intake and serum insulin responses to intraventricular infusions of insulin and IGF-I. Physiol. Behav. 50 (1991) 745-749
41. Friedlander A.L., Butterfield G.E., Moynihan S., Grillo J., Pollack M., Holloway L., Friedman L., Yesavage J., Matthias D., Lee S., Marcus R., and Hoffman A.R. One year of insulin-like growth factor I treatment does not affect bone density, body composition, or psychological measures in postmenopausal women. J. Clin. Endocrinol. Metab. 86 (2001) 1496-1503
42. Gonzalez d.l.V., Buno W., Pons S., Garcia-Calderat M.S., Garcia-Galloway E., and Torres-Aleman I. Insulin-like growth factor I potentiates kainate receptors through a phosphatidylinositol 3-kinase dependent pathway. Neuroreport 12 (2001) 1293-1296
43. Gruart A., Munoz M.D., and gado-Garcia J.M. Involvement of the CA3-CA1 synapse in the acquisition of associative learning in behaving mice. J. Neurosci. 26 (2006) 1077-1087
44. Grunbaum-Novak N., Taler M., Gil-Ad I., Weizmanm A., Cohen H., and Weizman R. Relationship between antidepressants and IGF-I system in the brain: possible role in cognition. Eur. Neuropsychopharmacol. 18 (2008) 431-438
45. Hanke S., and Mann M. The phosphotyrosine interactome of the insulin receptor family and its substrates IRS-1 and IRS-2. Mol. Cell. Proteomics (2008)
46. Harvey J., Shanley L.J., O'Malley D., and Irving A.J. Leptin: a potential cognitive enhancer?. Biochem. Soc. Trans. 33 (2005) 1029-1032
47. Hosback S., Hardiman O., Nolan C.M., Doyle M.A., Gorman G., Lynch C., O'Toole O., and Jakeman P. Circulating insulin-like growth factors and related binding proteins are selectively altered in amyotrophic lateral sclerosis and multiple sclerosis. Growth Horm. IGF Res. 17 (2007) 472-479
48. Hu Y., and Russek S.J. BDNF and the diseased nervous system: a delicate balance between adaptive and pathological processes of gene regulation. J. Neurochem. 105 (2008) 1-17
49. Huizer K., Van Beveren N., Roder C.H.R., De Jong F.H., and Fekkes D. Serum IGF-1 is decreased in recent onset schizophrenia patients. Schizophr. Res. 81 Suppl. S (2006) 208
50. Jones K.D., Deodhar A.A., Burckhardt C.S., Perrin N.A., Hanson G.C., and Bennett R.M. A combination of 6 months of treatment with pyridostigmine and triweekly exercise fails to improve insulin-like growth factor-I levels in fibromyalgia, despite improvement in the acute growth hormone response to exercise. J. Rheumatol. 34 (2007) 1103-1111
51. Kalmijn S., Janssen J.A., Pols H.A., Lamberts S.W., and Breteler M.M. A prospective study on circulating insulin-like growth factor I (IGF-I), IGF-binding proteins, and cognitive function in the elderly. J. Clin. Endocrinol. Metab. 85 (2000) 4551-4555
52. Kapczinski F., Frey B.N., Kauer-Sant'Anna M., and Grassi-Oliveira R. Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder. Expert. Rev Neurother. 8 (2008) 1101-1113
53. Kar S., Seto D., Dore S., Hanisch U., and Quirion R. Insulin-like growth factors-I and -II differentially regulate endogenous acetylcholine release from the rat hippocampal formation. Proc. Natl. Acad. Sci. USA 94 (1997) 14054-14059
54. Kilgard M. Cholinergic modulation of skill learning and plasticity. Neuron 38 (2003) 678-680
55. Kilgard M.P., Pandya P.K., Vazquez J., Gehi A., Schreiner C.E., and Merzenich M.M. Sensory input directs spatial and temporal plasticity in primary auditory cortex. J. Neurophysiol. 86 (2001) 326-338
56. Komulainen P., Pedersen M., Hanninen T., Bruunsgaard H., Lakka T.A., Kivipelto M., Hassinen M., Rauramaa T.H., Pedersen B.K., and Rauramaa R. BDNF is a novel marker of cognitive function in ageing women: The DR's EXTRA Study. Neurobiol. Learn. Mem. 90 (2008) 596-603
57. Kramer A.F., Erickson K.I., and Colcombe S.J. Exercise, cognition, and the aging brain. J. Appl. Physiol. 101 (2006) 1237-1242
58. Kubota N., Kubota T., Itoh S., Kumagai H., Kozono H., Takamoto I., Mineyama T., Ogata H., Tokuyama K., Ohsugi M., Sasako T., Moroi M., Sugi K., Kakuta S., Iwakura Y., Noda T., Ohnishi S., Nagai R., Tobe K., Terauchi Y., Ueki K., and Kadowaki T. Dynamic functional relay between insulin receptor substrate 1 and 2 in hepatic insulin signaling during fasting and feeding. Cell Metab. 8 (2008) 49-64
59. Landi F., Capoluongo E., Russo A., Onder G., Cesari M., Lulli P., Minucci A., Pahor M., Zuppi C., and Bernabei R. Free insulin-like growth factor-I and cognitive function in older persons living in community. Growth Horm. IGF Res. 17 (2007) 58-66
60. Le Roith D., and Roberts Jr. C.T. The insulin-like growth factor system and cancer. Cancer Lett. 195 (2003) 127-137
61. Le Roith D., Scavo L., and Butler A. What is the role of circulating IGF-I?. Trends Endocrinol. Metab. 12 (2001) 48-52
62. Lebrun B., Bariohay B., Moyse E., and Jean A. Brain-derived neurotrophic factor (BDNF) and food intake regulation: a minireview. Auton. Neurosci. 126-127 (2006) 30-38
63. Lezak M., Howieson D.B., and Loring D.W. Neuropsychological assessment (2004), Oxford University Press, Oxford
64. Lijffijt M., Van Dam P.S., Kenemans J.L., Koppeschaar H.P., de Vries W.R., Drent M.L., Wittenberg A., and Kemner C. Somatotropic-axis deficiency affects brain substrates of selective attention in childhood-onset growth hormone deficient patients. Neurosci. Lett. 353 (2003) 123-126
65. Liu Y.L., Yakar S., Otero-Corchon V., Low M.J., and Liu J.L. Ghrelin gene expression is age-dependent and influenced by gender and the level of circulating IGF-I. Mol. Cell. Endocrinol. 189 (2002) 97-103
66. Logothetis N.K. What we can do and what we cannot do with fMRI. Nature 453 (2008) 869-878
67. Lommatzsch M., Braun A., Mannsfeldt A., Botchkarev V.A., Botchkareva N.V., Paus R., Fischer A., Lewin G.R., and Renz H. Abundant production of brain-derived neurotrophic factor by adult visceral epithelia. Implications for paracrine and target-derived neurotrophic functions. Am. J. Pathol. 155 (1999) 1183-1193
68. Lopez-Lopez C., LeRoith D., and Torres-Aleman I. Insulin-like growth factor I is required for vessel remodeling in the adult brain. Proc. Natl. Acad. Sci. USA 101 (2004) 9833-9838
69. Luine V.N. Sex steroids and cognitive function. J. Neuroendocrinol. 20 (2008) 866-872
70. Malberg J.E., Platt B., Rizzo S.J., Ring R.H., Lucki I., Schechter L.E., and Rosenzweig-Lipson S. Increasing the levels of insulin-like growth factor-I by an IGF binding protein inhibitor produces anxiolytic and antidepressant-like effects. Neuropsychopharmacology 32 (2007) 2360-2368
71. Man Y.H., Lin J.W., Ju W.H., Ahmadian G., Liu L., Becker L.E., Sheng M., and Wang Y.T. Regulation of AMPA receptor-mediated synaptic transmission by clathrin-dependent receptor internalization. Neuron 25 (2000) 649-662
72. Markowska A.L., Mooney M., and Sonntag W.E. Insulin-like growth factor-1 ameliorates age-related behavioral deficits. Neuroscience 87 (1998) 559-569
73. Martinowich K., Manji H., and Lu B. New insights into BDNF function in depression and anxiety. Nat. Neurosci. 10 (2007) 1089-1093
74. Miyawaki T., Ofengeim D., Noh K.M., Latuszek-Barrantes A., Hemmings B.A., Follenzi A., and Zukin R.S. The endogenous inhibitor of Akt, CTMP, is critical to ischemia-induced neuronal death. Nat. Neurosci. 12 (2009) 618-626
75. Morley J.E., Kaiser F., Raum W.J., Perry III H.M., Flood J.F., Jensen J., Silver A.J., and Roberts E. Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone. Proc. Natl. Acad. Sci. USA 94 (1997) 7537-7542
76. Moschos S.J., and Mantzoros C.S. The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology 63 (2002) 317-332
77. Mitchell, J.D., Wokke, J.H., Borasio, G.D., 2007. Recombinant human insulin-like growth factor I (rhIGF-I) for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst. Rev., CD002064.
78. Moloney, A.M., Griffin, R.J., Timmons, S., O'Connor, R., Ravid, R., O'Neill, C. Defects in IGF-I receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-I and insulin signalling. Neurobiol. Aging, in press.
79. Nieto-Bona M.P., Garcia-Segura L.M., and Torres-Aleman I. Transynaptic modulation by insulin-like growth factor I of dendritic spines in Purkinje cells. Int. J. Dev. Neurosci. 15 (1997) 749-754
80. Nunez A., Carro E., and Torres-Aleman I. Insulin-like growth factor I modifies electrophysiological properties of rat brain stem neurons. J. Neurophysiol. 89 (2003) 3008-3017
81. O'Kusky J.R., Ye P., and D'Ercole A.J. Insulin-like growth factor-I promotes neurogenesis and synaptogenesis in the hippocampal dentate gyrus during postnatal development. J. Neurosci. 20 (2000) 8435-8442
82. Okereke O.I., Kang J.H., Ma J., Gaziano J.M., and Grodstein F. Midlife plasma insulin-like growth factor I and cognitive function in older men. J. Clin. Endocrinol Metab. 91 (2006) 4306-4312
83. Okereke O., Kang J.H., Ma J., Hankinson S.E., Pollak M.N., and Grodstein F. Plasma IGF-I levels and cognitive performance in older women. Neurobiol. Aging 28 (2007) 135-142
84. Paolisso G., Ammendola S., Del Buono A., Gambardella A., Riondino M., Tagliamonte M.R., Rizzo M.R., Carella C., and Varricchio M. Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function. J. Clin. Endocrinol. Metab. 82 (1997) 2204-2209
85. Papadakis M.A., Grady D., Black D., Tierney M.J., Gooding G.A., Schambelan M., and Grunfeld C. Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann. Intern. Med. 124 (1996) 708-716
86. Papadakis M.A., Grady D., Tierney M.J., Black D., Wells L., and Grunfeld C. Insulin-like growth factor 1 and functional status in healthy older men. J. Am. Geriatr. Soc. 43 (1995) 1350-1355
87. Papadakis M.A., Hamon G., Stotts N., Tierney M.J., Martin Spencer E., Scheuenstuhl H., and Hunt T.K. Effect of growth hormone replacement on wound healing in healthy older men. Wound Repair Regen. 4 (1996) 421-425
88. Pascual A., Hidalgo-Figueroa M., Piruat J.I., Pintado C.O., Gomez-Diaz R., and Lopez-Barneo J. Absolute requirement of GDNF for adult catecholaminergic neuron survival. Nat. Neurosci. 11 (2008) 755-761
89. Perrin M.A., Chen H., Sandberg D.E., Malaspina D., and Brown A.S. Growth trajectory during early life and risk of adult schizophrenia. Br. J. Psychiatry 191 (2007) 512-520
90. Rajpathak S.N., Gunter M.J., Wylie-Rosett J., Ho G.Y., Kaplan R.C., Muzumdar R., Rohan T.E., and Strickler H.D. The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes. Diabetes Metab. Res. Rev. 25 (2009) 3-12
91. Ramocki M.B., and Zoghbi H.Y. Failure of neuronal homeostasis results in common neuropsychiatric phenotypes. Nature 455 (2008) 912-918
92. Reger M.A., Watson G.S., Green P.S., Wilkinson C.W., Baker L.D., Cholerton B., Fishel M.A., Plymate S.R., Breitner J.C., DeGroodt W., Mehta P., and Craft S. Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology 70 (2008) 440-448 Erratum in: Neurology 2008 September 9;71(11):866
93. Reinhardt R.R., and Bondy C.A. Insulin-like growth factors cross the blood-brain barrier. Endocrinology 135 (1994) 1753-1761
94. Resnick S.M., Pham D.L., Kraut M.A., Zonderman A.B., and Davatzikos C. Longitudinal magnetic resonance imaging studies of older adults: a shrinking brain. J. Neurosci. 23 (2003) 3295-3301
95. Rollero A., Murialdo G., Fonzi S., Garrone S., Gianelli M.V., Gazzerro E., Barreca A., and Polleri A. Relationship between cognitive function, growth hormone and insulin-like growth factor I plasma levels in aged subjects. Neuropsychobiology 38 (1998) 73-79
96. Rubin L.L., and Staddon J.M. The cell biology of the blood-brain barrier. Annu. Rev. Neurosci. 22 (1999) 11-28
97. Russo V.C., Gluckman P.D., Feldman E.L., and Werther G.A. The insulin-like growth factor system and its pleiotropic functions in brain. Endocr. Rev. 26 (2005) 916-943
98. Sartorio A., Conti A., Molinari E., Riva G., Morabito F., and Faglia G. Growth, growth hormone and cognitive functions. Horm Res. 45 (1996) 23-29
99. Sathiavageeswaran M., Burman P., Lawrence D., Harris A.G., Falleti M.G., Maruff P., and Wass J. Effects of GH on cognitive function in elderly patients with adult-onset GH deficiency: a placebo-controlled 12-month study. Eur. J. Endocrinol. 156 (2007) 439-447
100. Seto D., Zheng W.H., McNicoll A., Collier B., Quirion R., and Kar S. Insulin-like growth factor-I inhibits endogenous acetylcholine release from the rat hippocampal formation: possible involvement of GABA in mediating the effects. Neuroscience 115 (2002) 603-612
101. Sevigny J.J., Ryan J.M., van Dyck C.H., Peng Y., Lines C.R., Nessly M.L., and MK-677 Protocol 3 Study Group. Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial. Neurology 71 (2008) 1702-1708
102. Silva A.J. Molecular and cellular cognitive studies of the role of synaptic plasticity in memory. J. Neurobiol. 54 (2003) 224-237
103. Soares C.N., Musolino N.R., Cunha Neto M., Caires M.A., Rosenthal M.C., Camargo C.P., and Bronstein M.D. Impact of recombinant human growth hormone (RH-GH) treatment on psychiatric, neuropsychological and clinical profiles of GH deficient adults. A placebo-controlled trial. Arq. Neuropsiquiatr. 57 (1999) 182-189
104. Sonntag W.E., Bennett S.A., Khan A.S., Thornton P.L., Xu X., Ingram R.L., and Brunso-Bechtold J.K. Age and insulin-like growth factor-1 modulate N-methyl-D-aspartate receptor subtype expression in rats. Brain Res. Bull. 51 (2000) 331-338
105. Steen E., Terry B.M., Rivera E.J., Cannon J.L., Neely T.R., Tavares R., Xu X.J., Wands J.R., and de la Monte S.M. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes?. J. Alzheimers Dis. 7 (2005) 63-80
106. Ster J., Colomer C., Monzo C., Duvoid-Guillou A., Moos F., Alonso G., and Hussy N. Insulin-like growth factor-1 inhibits adult supraoptic neurons via complementary modulation of mechanoreceptors and glycine receptors. J. Neurosci. 25 (2005) 2267-2276
107. Strachan M.W. Insulin and cognitive function. Lancet 362 (2003) 1253
108. Stranahan, A.M., Lee, K., Becker, K.G., Zhang, Y., Maudsley, S., Martin, B., Cutler, R.G., Mattson, M.P., 2008a. Hippocampal gene expression patterns underlying the enhancement of memory by running in aged mice. Neurobiol. Aging.
109. Stranahan A.M., Arumugam T.V., Cutler R.G., Lee K., Egan J.M., and Mattson M.P. Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat. Neurosci. 11 (2008) 309-317
110. Sun L.Y., Al Regaiey K., Masternak M.M., Wang J., and Bartke A. Local expression of GH and IGF-I in the hippocampus of GH-deficient long-lived mice. Neurobiol. Aging 26 (2005) 929-937
111. Tan H.Y., Nicodemus K.K., Chen Q., Li Z., Brooke J.K., Honea R., Kolachana B.S., Straub R.E., Meyer-Lindenberg A., Sei Y., Mattay V.S., Callicott J.H., and Weinberger D.R. Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans. J. Clin. Invest. 118 (2008) 2200-2208
112. Tham A., Nordberg A., Grissom F.E., Carlsson-Skwirut C., Viitanen M., and Saram V.R. Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer type. Neural Transm. Park. Dis. Dement. Sect. 5 (1993) 165-176
113. Thornton P.L., Ingram R.L., and Sonntag W.E. Chronic [D-Ala2]-growth hormone-releasing hormone administration attenuates age-related deficits in spatial memory. J. Gerontol. A Biol. Sci. Med. Sci. 55 (2000) B106-B112
114. Torres A.I. Role of insulin-like growth factors in neuronal plasticity and neuroprotection. Adv. Exp Med. Biol. 567 (2005) 243-258
115. Trejo J.L., Carro E., Garcia-Galloway E., and Torres-Aleman I. Role of insulin-like growth factor I signaling in neurodegenerative diseases. J. Mol. Med. 82 (2004) 156-162
116. Trejo J.L., Carro E., Lopez-Lopez C., and Torres-Aleman I. Role of serum insulin-like growth factor I in mammalian brain aging. Growth Horm. IGF. Res. 14 Suppl. A (2004) 39-43
117. Trejo J.L., Carro E., Nunez A., and Torres-Aleman I. Sedentary life impairs self-reparative processes in the brain: the role of serum insulin-like growth factor-I. Rev. Neurosci. 13 (2002) 365-374
118. Trejo J.L., Llorens-Martin M.V., and Torres-Aleman I. The effects of exercise on spatial learning and anxiety-like behavior are mediated by an IGF-I-dependent mechanism related to hippocampal neurogenesis. Mol. Cell. Neurosci. 37 (2008) 402-411
119. Trejo J., Piriz J., Llorens-Martin M.V., Fernandez A.M., Bolos M., LeRoith D., Nunez A., and Torres-Aleman I. Central actions of liver-derived insulin-like growth factor I underlying its pro-cognitive effects. Mol. Psychiatry 12 (2007) 1118-1128
120. Ukkola O., Poykko S., Paivansalo M., and Kesaniemi Y.A. Interactions between ghrelin, leptin and IGF-I affect metabolic syndrome and early atherosclerosis. Ann. Med. 40 (2008) 465-473
121. Van Dam P.S., and Aleman A. Insulin-like growth factor-I, cognition and brain aging. Eur. J. Pharmacol. 490 (2004) 87-95
122. Van Dam P.S., de Winter C.F., de Vries R., van der Grond J., Drent M.L., Lijffijt M., Kenemans J.L., Aleman A., de Haan E.H., and Koppeschaar H.P. Childhood-onset growth hormone deficiency, cognitive function and brain N-acetylaspartate. Psychoneuroendocrinology 30 (2005) 357-363
123. Vardy E.R., Rice P.J., Bowie P.C., Holmes J.D., Grant P.J., and Hooper N.M. Increased circulating insulin-like growth factor-1 in late-onset Alzheimer's disease. J. Alzheimers Dis. 12 (2007) 285-290
124. Venkatasubramanian G., Chittiprol S., Neelakantachar N., Naveen M.N., Thirthall J., Gangadhar B.N., and Shetty K.T. Insulin and insulin-like growth factor-1 abnormalities in antipsychotic-naïve schizophrenia. Am. J. Psychiatry 164 (2007) 1557-1560
125. Vitiello M.V., Moe K.E., Merriam G.R., Mazzoni G., Buchner D.H., and Schwartz R.S. Growth hormone releasing hormone improves the cognition of healthy older adults. Neurobiol. Aging 27 (2006) 318-323
126. Watanabe T., Miyazaki A., Katagiri T., Yamamoto H., Idei T., and Iguchi T. Relationship between serum insulin-like growth factor-1 levels and Alzheimer's disease and vascular dementia. J. Am. Geriatr. Soc. 53 (2005) 1748-1753
127. Wang H., Ward N., Boswell M., and Katz D.M. Secretion of brain-derived neurotrophic factor from brain microvascular endothelial cells. Eur. J. Neurosci. 23 (2006) 1665-1670
128. Wang Y.T., and Linden D.J. Expression of cerebellar long-term depression requires postsynaptic clathrin-mediated endocytosis. Neuron 25 (2000) 635-647
129. Weber-Hamann B., Blum W.F., Kratzsch J., Gilles M., Heuser I., and Deuschle M. Insulin-like growth factor-I (IGF-I) serum concentrations in depressed patients: relationship to saliva cortisol and changes during antidepressant treatment. Pharmacopsychiatry 42 (2009) 23-28
130. Woods K.A., Camacho-Hubner C., Barter D., Clark A.J., and Savage M.O. Insulin-like growth factor I gene deletion causing intrauterine growth retardation and severe short stature. Acta Paediatr. Suppl. 423 (1997) 39-45
131. Yakar S., Liu J.L., Stannard B., Butler A., Accili D., Sauer B., and LeRoith D. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc. Natl. Acad. Sci. USA 96 (1999) 7324-7329
132. Zhang W., and Linden D.J. The other side of the engram: experience-driven changes in neuronal intrinsic excitability. Nat. Rev. Neurosci. 4 (2003) 885-900
133. Zhang J., Moats-Staats B.M., Ye P., and D'Ercole A.J. Expression of insulin-like growth factor system genes during the early postnatal neurogenesis in the mouse hippocampus. J. Neurosci. Res. 85 (2007) 1618-1627
134. Zona C., Ciotti M.T., and Calissano P. Human recombinant IGF-I induces the functional expression of AMPA/kainate receptors in cerebellar granule cells. Neurosci. Lett. 186 (1995) 75-78